We are live on ! Find out more
MD icon

Pediatrix Medical

229 hedge funds and large institutions have $1.08B invested in Pediatrix Medical in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 80 increasing their positions, 74 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,161% more call options, than puts

Call options by funds: $701K | Put options by funds: $31K

59% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 22

8% more capital invested

Capital invested by funds: $995M → $1.08B (+$84.6M)

5% more funds holding

Funds holding: 218229 (+11)

8% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 74

4.29% less ownership

Funds ownership: 100.11%95.82% (-4.3%)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
229
Holders Change
+11
Holders Change %
+5.05%
% of All Funds
3.02%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
35
Increased
80
Reduced
74
Closed
22
Calls
$701K
Puts
$31K
Net Calls
+$670K
Net Calls Change
+$328K
Name Holding Trade Value Shares
Change
Change in
Stake
N
151
Numerai
California
$214K +$225K +16,275 New
Bank of Montreal
152
Bank of Montreal
Ontario, Canada
$196K -$5.38M -389,965 -96%
SC
153
Savant Capital
Illinois
$195K +$1.15K +83 +0.6%
Pictet Asset Management
154
Pictet Asset Management
Switzerland
$191K +$78.4K +5,677 +64%
BCM
155
Bayesian Capital Management
New York
$190K +$200K +14,500 New
RWM
156
Ritholtz Wealth Management
New York
$182K +$192K +13,883 New
ECM
157
Everence Capital Management
Indiana
$182K +$13.3K +960 +7%
AC
158
AXQ Capital
New Jersey
$180K +$189K +13,698 New
Neuberger Berman Group
159
Neuberger Berman Group
New York
$178K +$6.18K +448 +3%
Public Employees Retirement Association of Colorado
160
Public Employees Retirement Association of Colorado
Colorado
$177K
SG Americas Securities
161
SG Americas Securities
New York
$171K +$180K +13,062 New
XT
162
XTX Topco
Cayman Islands
$169K +$178K +12,917 New
MOACM
163
Mutual of America Capital Management
New York
$168K +$1.28K +93 +0.7%
QCM
164
Quantinno Capital Management
New York
$163K +$7.41K +537 +5%
B
165
Bailard
California
$161K +$170K +12,300 New
HW
166
Hancock Whitney
Mississippi
$160K +$168K +12,166 New
Envestnet Asset Management
167
Envestnet Asset Management
Illinois
$145K -$1.88K -136 -1%
CC
168
Centiva Capital
New York
$139K -$223K -16,127 -60%
SPA
169
Sherbrooke Park Advisers
New York
$136K +$143K +10,385 New
VPIM
170
Vanguard Personalized Indexing Management
California
$134K -$8.46K -613 -6%
Squarepoint
171
Squarepoint
New York
$132K +$139K +10,049 New
GC
172
Globeflex Capital
California
$129K
AIP
173
Ameritas Investment Partners
Nebraska
$110K
Carson Wealth (CWM LLC)
174
Carson Wealth (CWM LLC)
Nebraska
$105K +$22.1K +1,600 +25%
TRCT
175
Tower Research Capital (TRC)
New York
$97.7K +$70.5K +5,104 +218%

MD Hedge Fund Activity: Q4 2024 in Review

229 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2024, worth a combined $1.08B — up 8.5% from $995M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new MD positions and 22 closed out — a net gain of 13 holders — while 80 added to existing stakes and 74 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $40M. The largest seller was Rubric Capital Management (New York), cutting an estimated $70.8M.

  • 229 institutional investors held Pediatrix Medical (MD) as of Q4 2024, up from 218 in Q3 2024.
  • Funds reported $1.08B of Pediatrix Medical stock for Q4 2024, up 8.5% quarter-over-quarter.
  • 35 funds opened new Pediatrix Medical positions in Q4 2024 and 22 closed out, a net change of +13 holders.
  • The largest Pediatrix Medical buyer in Q4 2024 was Fidelity Investments, an estimated $40M added.
  • The largest Pediatrix Medical seller in Q4 2024 was Rubric Capital Management (New York), an estimated $70.8M sold.

Based on aggregated 13F filings for Q4 2024.